Trials / Terminated
TerminatedNCT00279565
Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)
Randomized, Controlled Study of Buprenorphine and Methadone in Hepatitis C Patients in Need of Treatment
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 128 (planned)
- Sponsor
- Indivior Inc. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, single-center, controlled study is designed to evaluate the safety, tolerability, and efficacy of treatment with Peg-Intron with Rebetol in methadone or buprenorphine maintenance patients with hepatitis C.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | buprenorphine | |
| DRUG | methadone | |
| DRUG | pegylated interferon alfa-2b plus ribavirin |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2007-02-01
- Completion
- 2007-02-01
- First posted
- 2006-01-19
- Last updated
- 2012-11-22
Source: ClinicalTrials.gov record NCT00279565. Inclusion in this directory is not an endorsement.